Rxo, INC Form 4 insider transactions

NYSE
RXO's Chief Financial Officer, James E. Harris, reported the vesting of restricted stock units and a new performance-based equity award.
NYSE
RXO's Chief Legal Officer, Jeffrey D. Firestone, reported the vesting of restricted stock units and the grant of new performance-based awards.
NYSE
RXO, Inc. Director Thomas A. Szlosek was granted 14,517 Restricted Stock Units, vesting in 2027, and deferred 7,745 previously vested units.
NYSE
RXO, Inc. Director Stephen M. Renna reported the vesting and settlement of Restricted Stock Units and the grant of new RSUs.
NYSE
RXO, Inc. Director Michelle Nettles was granted 14,517 Restricted Stock Units, which will vest in 2027 and are subject to a deferral election.
NYSE
RXO Director Mary E. Kissel reported an increase in beneficial ownership of common stock and received a new grant of Restricted Stock Units.
NYSE
RXO, Inc. Director Adrian Kingshott was granted 14,517 Restricted Stock Units, vesting in 2027, and deferred 7,745 previously vested units.
NYSE
RXO Director Troy A. Cooper increased his direct common stock ownership by 7,745 shares and received a new grant of 14,517 Restricted Stock Units, vesting in 2027.
NYSE
RXO Director Christine Breves reported the vesting of 7,745 restricted stock units into common stock and the grant of 14,517 new restricted stock units.
NYSE
RXO, Inc. Director Troy A. Cooper acquired 8,317 shares of common stock at a weighted average price of $10.61, increasing his beneficial ownership.
NYSE
RXO Director Adrian Kingshott acquired 9,350 shares of common stock at a weighted average price of $10.75, increasing his direct beneficial ownership.
NYSE
RXO Director Adrian Kingshott acquired 9,350 common shares at $10.75 each, increasing his total beneficial ownership to 91,137 shares.
NYSE
RXO's CEO, Andrew M. Wilkerson, reported changes in his beneficial ownership of company stock following the vesting and settlement of Restricted Stock Units.
NYSE
RXO's Chief Accounting Officer, Jason S. Kerr, sold 33,343 shares of common stock for a weighted average price of $11.57 per share.
NYSE
RXO Director Thomas A. Szlosek purchased 20,308 shares of common stock and subsequently transferred 49,542 shares into a grantor retained annuity trust, retaining beneficial ownership.
NYSE
Andrew M. Wilkerson, CEO and Director of RXO, Inc., acquired additional common stock totaling $149,478, demonstrating increased personal investment in the company.
NYSE
RXO CEO Andrew M. Wilkerson transferred indirect interests in a limited liability company holding company shares to family trusts for estate planning purposes.
NYSE
RXO's Chief Accounting Officer, Jason S. Kerr, had 9,518 shares withheld by the company to cover tax liabilities related to restricted stock release.
NYSE
RXO Inc.'s Chief Financial Officer, James E. Harris, reported the vesting of 64,130 Restricted Stock Units and the subsequent withholding of 28,025 shares for tax obligations.
NYSE
RXO's Chief Legal Officer, Jeffrey D. Firestone, reported the scheduled vesting of Restricted Stock Units and associated tax withholding for August 31, 2025.
NYSE
RXO's Chief Legal Officer, Jeffrey D. Firestone, reported the vesting and settlement of Restricted Stock Units, with shares withheld for tax obligations.
NYSE
Director Thomas A. Szlosek of RXO, Inc. recently purchased 7,500 shares of common stock at an average price of $16.65, increasing his indirect holdings.
NYSE
Director Thomas A. Szlosek of RXO, Inc. reports the acquisition of 8,700 shares of common stock at a weighted average price of $14.4085.
NYSE
RXO CEO Andrew Wilkerson reports the vesting and settlement of restricted stock units (RSUs) and the withholding of shares for tax liability.
NYSE
Jeffrey D. Firestone, Chief Legal Officer of RXO, Inc., reports the vesting and settlement of restricted stock units (RSUs) and associated tax withholding.
NYSE
Chief Accounting Officer Jason S. Kerr of RXO Inc. reports the vesting and settlement of restricted stock units, along with associated tax withholding.
NYSE
James Harris, CFO of RXO, Inc., reports the vesting and settlement of Restricted Stock Units (RSUs) and associated tax withholding.
NYSE
Andrew Wilkerson, CEO of RXO, Inc., reports the vesting and settlement of Restricted Stock Units (RSUs) and associated tax withholding.
NYSE
RXO, Inc. CEO Andrew Wilkerson reports the vesting and settlement of restricted stock units (RSUs) and associated tax withholding.
NYSE
Jeffrey D. Firestone, Chief Legal Officer of RXO Inc., amends a previous SEC filing to correct the reporting of Performance Based Restricted Stock Units (PSUs) acquired.